Company Profiles

TODAY : Monday, 21 April 2025

Code

KLBF

Title

PT. Kalbe Farma Tbk

Address

Head Office	:
Address	:	Gedung KALBE
		Jl. Let.Jend Suprapto Kav 4, Cempaka Putih - Jakarta Pusat 10510
Phone	:	(021) 4287 3888
Fax	:	(021) 4287 3680
E-mail	:	info@kalbe.co.id
Website	:	www.kalbe.co.id
Marketing Office	:
		Enseval Building
		Jl. Let.Jend. Suprapto - Jakarta 10510
Phone	:	(021) 4287.3888
Fax	:	(021) 4287.3680
E-mail	:	info@kalbe.co.id
Website	:	www.kalbe.co.id
Manufacture	:
		Jl. Jend. A. Yani (Pulomas)
		Jakarta Timur 13210
Phone	:	(021) 489 2808
Fax	:	(021) 489 3549; (021) 489 1502
E-mail	:	info@kalbe.co.id
Website	:	www.kalbe.co.id

Background

The Company is primarily engaged in the development, manufacturing and trading of pharmaceutical preparation including medicines and consumer health products.

Business cp product

The Company is primarily engaged in the development, manufacturing and trading of pharmaceutical preparation including medicines and consumer health products.

Subsidiary affiliation

Subsidiaries	Domicile	Business	%
Pharmaceutical
PT Bintang Toedjoe	Jakarta	Pharmaceutical	100
PT Hexpharm Jaya Laboratories	Jakarta	Pharmaceutical	100
PT Saka Farma Laboratories	Jakarta	Pharmaceutical	100
PT Finusolprima Farma Int.	Jakarta	Pharmaceutical	100
PT Bifarma Adiluhung	Jakarta	Health screening service	100
Innogene Kalbiotech Pte. Ltd.	Singapore	Agent and representative for biotechnology products	93.34
PT Dankos Farma	Jakarta	Pharmaceutical	100
PT Pharma Metric Labs.	Jakarta	Quality Control Certification Service and	81.64
		Clinical Trial for Pharmaceutical and Consumer Health Products
PT KalGen DNA	Jakarta	Screening Service, Supporting Diagnostic Test and Reagen Production	60
PT Kalbio Global Medika	Jakarta	Manufacturing of Biologic Products	100
PT Kalbe Genexine Biologics	Jakarta	Pharmaceutical	60
PT Innolab Sains Internasional	Jakarta	Health Screening Service	60
PT global Onkolab Farma	Jakarta	Pharmaceutical	100
PT Kalbe Myanmar Company Ltd.	Myanmar	Pharmaceutical	100
Health Foods and Drinks
PT Sanghiang Perkasa	Jakarta	Health Foods	100
PT Kalbe Morinaga Indonesia	Jakarta	Health Foods	70
PT Hale International	Bogor	Health Drinks	100
PT Kalbe Milko Indonesia	Bogor	Health Foods	51
PT global Vita Nutritech	Jakarta	Premix Industry	100
Sale and Distribution
PT Enseval Putera Megatrading Tbk	Jakarta	Distribution of Pharmaceutical Products,	91.8
		Consumer Products, Medical Equipment,
		Cosmetics and Other Trading Products
PT Tri Sapta Jaya	Jakarta	Distribution of Pharmaceutical Products and	91.8
		Medical Equipment
PT Millenia Dharma Insani	Jakarta	Health Care Clinics	91.8
PT Enseval Medika Prima	Jakarta	Trading of Medical and Laboratory Equipment and Supplies	91.8
PT Global Chemindo Megatrading	Jakarta	Trading of Raw Materials for Pharmaceutical	91.8
		Products
PT Global Karsa Medika	Jakarta	Wholesale trading of pharmaceutical, medical equipment, foods and drinks	91.8
PT Renalmed Tiara Utama	Jakarta	Trading of Consumable Products for	90.65
		Hemodialysis Therapy
Kalbe Vision Pte. Ltd.	Singapore	Development, Production, Marketing and	100
		Distribution of Opthalmic Products
Kalbe International Pte.Ltd.	Singapore	Wholesale of Pharmaceutical, Consumer Health and Nutrition Products	100
Asiawide Kalbe Philippines, Inc.	Philippines	Marketing and Distribution of Energy Drinks in a Ready-to-Drink Format	50
PT Karsa Lintas Buwana	Jakarta	Advertising	100
Kalbe Malaysia Sdn. Bhd.	Malaysia	Wholesale of Pharmaceutical and Medical	100
		Products
PT Medika Renal Citraprima	Jakarta	Hemodialysis Clinic, Trading of Consumable	91.8
		Products for Hemodialysis Therapy
PT Medika Komunika Teknologi	Jakarta	E-commerce, web portal and online media services	50
PT Cakra Radha Mustika	Jakarta	Digital marketing services	100
PT Karya Hasta Dinamika	Jakarta	Home delivery service	100
Kalbe Global Pte. Ltd	Singapore	Holding company	100

Commissioners

President Commissioner	: Bernadette Ruth Irawati Setiady
Commissioner	: Santoso Oen
Commissioner	: Ronny Hadiana
Commissioner	: Budi Dharma Wreksoatmodjo
Independent Commissioner	: Rhenald Kasali
Independent Commissioner	: Lilis Halim

Per 30 Sep 2023

Directors

President Director	: Vidjongtius
Director	: Bernadus Karmin Winata
Director	: Sie Djohan
Director	: Mulialie
Director	: Jos Iwan Atmadjaja
Director	: Kartika Setiabudy

Per 30 Sep 2023

Underwriter

PT. Merincorp

PT. Niaga Securities

Share registrar

PT. Adimitra Transferindo

Share holders

Shareholders	Shares	%
PT. Gira Sole Prima	4824509485	10.29
PT. Santa Seha Sanadi	4718121940	10.07
PT. Diptanala Bahana	4454807040	9.5
PT. Lucasta Murni Cemerlang	4439895440	9.47
PT. Ladang Ira Panen	4903185740	10.46
PT. Bina Artha Charisma	3841639040	8.2
B.R. Irawati Setiady	21588000	0.05
Ronny Hadiana	91071007	0.19
Mulialie	250045	0
Public (< 5%)	18960573673	40.69
Treasury Stock	619480700	1.32

As of Sep 30, 2022

History stocks

Type of ListingDatePrice## of SharesTotal Listed Shares

IPO @ Rp. 7,80030-Jul-199110001000000050000000

1:1 Bonus Issue30-Oct-1992100050000000100000000

8:100 Rights @ Rp. 8,53030-Apr-199310008000000108000000

3:10 Stock Div.16-Jun-1994100032400000140400000

7;10 Bonus Issue30-Jun-1994100075600000216000000

Stock Split2-Oct-1996500216000000432000000

Stock Split24-Sep-199910017280000002160000000

Bonus Issue06-Dec-200010019008000004060800000

Stock Split02-Jan-20045040608000008121600000

Conversion DNKS (PT. Dankos)21-Dec-2005506836419068805241906

Conversion PT. Enseval21-Dec-200550135077251610156014422

Stock Split 1 : 508-Oct-2012104062405768850780072110

Decrease in Issued and Fully Paid Shares13-Dec-201310-390495000046875122110

Other infos

International Activities

Sales mostly generated by OTC (Over the Counter) products such as WOODS, MIXAGRIP, PROCOLD, MEDIK 55, PROMAG, ZAIKI, CORINZHA and MILNA.

Per 21 December 2005, Merger PT. Dankos Laboratories Tbk (DNKS) & PT. Enseval

Created date

2023-11-02 14:54:54

Revised date

2023-11-02 14:54:54

Finance

PT. Kalbe Farma Tbk

2023, 2022, 2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013,

Financial Statetment Date

Fiscal Year Ends

Months Covered in Income St

Summary Covered in Income St

Cash and Cash Equivalents

Receivables

Inventories

Current Assets

Fixed Assets

Other Assets

Non Current Assets

Total Assets

Current Liabilities

Longterm Liabilities

Total Liabilities

Authorized

Paid-up Capital

Par Value

Paid-up Capital Shares

Retained Earnings

Total Equity

Minority Interest

Summary of Income Statement

Total Sales

Cost of Good Sold

Gross Profit

Operating Profit

Other Income

Earning Before Tax

Tax

Net Income

Close Price

Per Share Data (Rp)

Eps (annualized)

Book Value

Financial Ratios

Debt Equity Ratio (X)

Roa(%)

Roe(%)

Npm(%)

Opm(%)

Gross Profit Margin (%)

Total Assets Turnover

Cash Flow

CF from Operation Activities

CF from Investing Activities

CF from Financing Activities

Net Increase in Cash & Cash Equivalent

Cash & Cash Equivalent at Beginning of the Year

Cash & Cash Equivalent at The End of the Year

2013-12-31	2013-09-30	2013-06-30
Dec	Dec	Dec
12	9	6


1,356,186,110.25	1,084,707,292.77	1,903,601,253.27
2,273,378,788.42	2,292,903,590.01	2,203,675,826.99
3,053,494,513.85	2,720,513,433.81	2,586,624,133.99
7,497,319,451.54	6,934,996,851.07	7,483,861,591.59
2,925,546,783.05	2,734,624,182.34	2,611,517,728.71
357,861,014.91	321,181,884.43	318,846,160.59
0.00	0.00	0.00
11,315,061,275.03	10,451,743,691.53	10,868,696,853.80
2,640,590,023.75	2,367,735,950.21	3,262,993,017.18
174,513,285.70	163,271,946.69	158,598,205.58
2,815,103,309.45	2,531,007,896.89	3,421,591,222.77
85,000,000.00	85,000,000.00	85,000,000.00
468,751,221.10	507,800,721.10	507,800,721.10
10.00	10.00	10.00
46,875,122.11	50,780,072.11	50,780,072.11
7,633,188,370.75	7,726,235,192.25	7,282,099,388.04
8,108,241,521.50	7,557,489,393.46	7,091,429,680.46
391,716,444.07	363,246,401.18	355,675,950.58


16,002,131,057.05	11,439,694,257.74	7,421,128,221.52
8,323,017,600.99	5,868,531,191.23	3,798,429,595.87
7,679,113,456.06	5,571,163,066.51	3,622,698,625.65
2,686,128,055.91	1,944,933,752.59	1,276,426,167.77
-113,605,338.68	-131,327,971.53	-49,949,659.79
2,572,522,717.23	1,813,605,781.06	1,226,476,507.99
602,070,267.55	412,753,035.05	278,434,279.50
1,919,508,370.31	1,366,122,455.94	921,986,651.73
1,250.00	1,180.00	1,440.00


40.95	35.87	36.31
172.98	148.83	139.65


0.35	0.33	0.48
16.96	17.43	16.97
23.67	24.10	26.00
12.00	11.94	12.42
16.79	17.00	17.20
0.00	0.00	0.00
0.00	0.00	0.00


927,163,654.21	717,227,811.15	376,683,560.13
-882,146,088.04	-671,056,248.82	-517,237,436.15
-613,320,636.89	-844,101,167.67	215,233,580.12
-568,303,070.72	-797,929,605.34	74,679,704.09
1,829,015,133.01	1,859,662,706.07	1,829,015,133.01
1,356,186,110.25	1,084,707,292.77	1,903,601,253.27

← Back to CPCA View